Jupiter Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.5M Buy
204,149
+189,239
+1,269% +$26.5M 0.15% 172
2025
Q4
$1.83M Buy
14,910
+5,790
+63% +$704K 0.01% 326
2025
Q3
$1.01M Buy
+9,120
New +$1.04M 0.01% 348
2025
Q2
Sell
-693,707
Closed -$77.7M 467
2025
Q1
$77.7M Buy
+693,707
New +$71.6M 0.75% 24
2024
Q2
Sell
-7,077
Closed -$518K 418
2024
Q1
$518K Sell
7,077
-90,520
-93% -$6.96M ﹤0.01% 389
2023
Q4
$7.91M Buy
97,597
+55,112
+130% +$4.29M 0.08% 234
2023
Q3
$3.18M Buy
42,485
+33,766
+387% +$2.6M 0.04% 287
2023
Q2
$672K Sell
8,719
-350,236
-98% -$27.9M 0.01% 448
2023
Q1
$29.8M Buy
+358,955
New +$29.7M 0.41% 74
2022
Q1
Sell
-3,161
Closed -$232K 554
2021
Q4
$232K Buy
+3,161
New +$218K ﹤0.01% 531
2021
Q1
Sell
-89,166
Closed -$5.19M 596
2020
Q4
$5.19M Buy
89,166
+29,690
+50% +$1.79M 0.05% 306
2020
Q3
$3.75M Buy
+59,476
New +$4.12M 0.04% 333
2020
Q2
Sell
-67,612
Closed -$5.05M 268
2020
Q1
$5.05M Sell
67,612
-166,240
-71% -$11.5M 0.22% 117
2019
Q4
$15.2M Sell
233,852
-17,537
-7% -$1.14M 0.47% 50
2019
Q3
$15.9M Sell
251,389
-8,000
-3% -$523K 0.52% 46
2019
Q2
$17.5M Buy
259,389
+15,692
+6% +$1.03M 0.56% 49
2019
Q1
$15.8M Buy
243,697
+4,700
+2% +$312K 0.51% 51
2018
Q4
$15M Buy
238,997
+22,600
+10% +$1.58M 0.52% 51
2018
Q3
$16.6M Buy
216,397
+41,200
+24% +$3.11M 0.47% 61
2018
Q2
$12.4M Hold
175,197
0.36% 78
2018
Q1
$13.2M Buy
175,197
+51,000
+41% +$4.05M 0.4% 71
2017
Q4
$8.9M Buy
124,197
+36,597
+42% +$2.78M 0.26% 103
2017
Q3
$7.1M Buy
87,600
+27,200
+45% +$2.08M 0.24% 96
2017
Q2
$4.28M Buy
60,400
+19,300
+47% +$1.28M 0.15% 154
2017
Q1
$2.79M Buy
+41,100
New +$2.89M 0.1% 190

Other funds holding GILD

Jupiter Asset Management's GILD Position: Q1 2026 in Review

Jupiter Asset Management increased its Gilead Sciences (GILD) stake by 1,269% in Q1 2026, buying an estimated $26.5M and bringing the position to 204,149 shares worth $28.5M. The position accounts for 0.15% of the portfolio, ranked #172.

Jupiter Asset Management first reported a position in GILD in Q1 2017 and has held it in 25 quarters since. The position peaked at $77.7M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jupiter Asset Management held 204,149 shares of Gilead Sciences worth $28.5M as of Q1 2026.
  • Jupiter Asset Management bought 189,239 Gilead Sciences shares in Q1 2026, an estimated $26.5M.
  • Gilead Sciences made up 0.15% of Jupiter Asset Management's portfolio in Q1 2026, its #172 holding.
  • Jupiter Asset Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 25 quarters since.
  • Jupiter Asset Management's Gilead Sciences position peaked at $77.7M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jupiter Asset Management's 13F filing for Q1 2026, filed 12 May 2026.